SEASTAR MEDICAL HOLDING CORP (ICU) Fundamental Analysis & Valuation

NASDAQ:ICU • US81256L3024

Current stock price

4.31 USD
+0.75 (+21.07%)
At close:
4.2936 USD
-0.02 (-0.38%)
After Hours:

This ICU fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. ICU Profitability Analysis

1.1 Basic Checks

  • In the past year ICU has reported negative net income.
  • In the past year ICU has reported a negative cash flow from operations.
  • In the past 5 years ICU always reported negative net income.
  • In the past 5 years ICU always reported negative operating cash flow.
ICU Yearly Net Income VS EBIT VS OCF VS FCFICU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 -5M -10M -15M -20M -25M

1.2 Ratios

  • ICU's Return On Assets of -85.82% is on the low side compared to the rest of the industry. ICU is outperformed by 78.72% of its industry peers.
  • The Return On Equity of ICU (-116.65%) is worse than 66.49% of its industry peers.
Industry RankSector Rank
ROA -85.82%
ROE -116.65%
ROIC N/A
ROA(3y)-455.2%
ROA(5y)-522.93%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ICU Yearly ROA, ROE, ROICICU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 0 500 -500 1K 1.5K

1.3 Margins

  • ICU's Gross Margin of 95.70% is amongst the best of the industry. ICU outperforms 98.94% of its industry peers.
  • The Profit Margin and Operating Margin are not available for ICU so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 95.71%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ICU Yearly Profit, Operating, Gross MarginsICU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 -5K -10K -15K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. ICU Health Analysis

2.1 Basic Checks

  • ICU has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, ICU has more shares outstanding
  • The debt/assets ratio for ICU has been reduced compared to a year ago.
ICU Yearly Shares OutstandingICU Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 1M 2M 3M
ICU Yearly Total Debt VS Total AssetsICU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 5M 10M

2.2 Solvency

  • Based on the Altman-Z score of -14.43, we must say that ICU is in the distress zone and has some risk of bankruptcy.
  • ICU has a worse Altman-Z score (-14.43) than 86.17% of its industry peers.
  • There is no outstanding debt for ICU. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -14.43
ROIC/WACCN/A
WACCN/A
ICU Yearly LT Debt VS Equity VS FCFICU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 5M -5M 10M -10M -15M

2.3 Liquidity

  • A Current Ratio of 3.63 indicates that ICU has no problem at all paying its short term obligations.
  • ICU has a Current ratio of 3.63. This is in the better half of the industry: ICU outperforms 60.11% of its industry peers.
  • A Quick Ratio of 3.61 indicates that ICU has no problem at all paying its short term obligations.
  • ICU has a Quick ratio of 3.61. This is in the better half of the industry: ICU outperforms 70.21% of its industry peers.
Industry RankSector Rank
Current Ratio 3.63
Quick Ratio 3.61
ICU Yearly Current Assets VS Current LiabilitesICU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. ICU Growth Analysis

3.1 Past

  • ICU shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 89.33%, which is quite impressive.
  • ICU shows a strong growth in Revenue. In the last year, the Revenue has grown by 814.07%.
EPS 1Y (TTM)89.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%91.11%
Revenue 1Y (TTM)814.07%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%526.87%

3.2 Future

  • Based on estimates for the next years, ICU will show a very strong growth in Earnings Per Share. The EPS will grow by 30.11% on average per year.
  • ICU is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 47.01% yearly.
EPS Next Y59.54%
EPS Next 2Y30.11%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year54.99%
Revenue Next 2Y47.01%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

ICU Yearly Revenue VS EstimatesICU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2025 2026 2027 1M 2M 3M
ICU Yearly EPS VS EstimatesICU Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 -50 -100 -150 -200 -250

More info and screens

Find the best growth stocksShow best growing peers

1

4. ICU Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ICU. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ICU. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ICU Price Earnings VS Forward Price EarningsICU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ICU Per share dataICU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4 -6 -8

4.3 Compensation for Growth

  • ICU's earnings are expected to grow with 30.11% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.11%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ICU Dividend Analysis

5.1 Amount

  • No dividends for ICU!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ICU Fundamentals: All Metrics, Ratios and Statistics

SEASTAR MEDICAL HOLDING CORP

NASDAQ:ICU (4/2/2026, 8:00:02 PM)

After market: 4.2936 -0.02 (-0.38%)

4.31

+0.75 (+21.07%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-25
Earnings (Next)05-12
Inst Owners2.21%
Inst Owner Change-99.98%
Ins Owners2.53%
Ins Owner Change0.65%
Market Cap15.52M
Revenue(TTM)1.23M
Net Income(TTM)-12.15M
Analysts80
Price Target9.18 (112.99%)
Short Float %4.78%
Short Ratio1.27
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.73%
Min EPS beat(2)14.19%
Max EPS beat(2)25.28%
EPS beat(4)4
Avg EPS beat(4)28.56%
Min EPS beat(4)14.19%
Max EPS beat(4)58.55%
EPS beat(8)6
Avg EPS beat(8)15%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-7.94%
Min Revenue beat(2)-27.52%
Max Revenue beat(2)11.64%
Revenue beat(4)3
Avg Revenue beat(4)36.21%
Min Revenue beat(4)-27.52%
Max Revenue beat(4)93.4%
Revenue beat(8)3
Avg Revenue beat(8)-15.15%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)800%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-863.64%
EPS NY rev (1m)-0.31%
EPS NY rev (3m)-915.87%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)52.04%
Revenue NY rev (1m)0%
Revenue NY rev (3m)44.43%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 12.57
P/FCF N/A
P/OCF N/A
P/B 1.49
P/tB 1.49
EV/EBITDA N/A
EPS(TTM)-8.3
EYN/A
EPS(NY)-3.36
Fwd EYN/A
FCF(TTM)-3.78
FCFYN/A
OCF(TTM)-3.78
OCFYN/A
SpS0.34
BVpS2.89
TBVpS2.89
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -85.82%
ROE -116.65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 95.71%
FCFM N/A
ROA(3y)-455.2%
ROA(5y)-522.93%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.63
Quick Ratio 3.61
Altman-Z -14.43
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)89.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%91.11%
EPS Next Y59.54%
EPS Next 2Y30.11%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)814.07%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%526.87%
Revenue Next Year54.99%
Revenue Next 2Y47.01%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y31.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y15.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y15.04%
OCF growth 3YN/A
OCF growth 5YN/A

SEASTAR MEDICAL HOLDING CORP / ICU Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for SEASTAR MEDICAL HOLDING CORP?

ChartMill assigns a fundamental rating of 3 / 10 to ICU.


Can you provide the valuation status for SEASTAR MEDICAL HOLDING CORP?

ChartMill assigns a valuation rating of 1 / 10 to SEASTAR MEDICAL HOLDING CORP (ICU). This can be considered as Overvalued.


Can you provide the profitability details for SEASTAR MEDICAL HOLDING CORP?

SEASTAR MEDICAL HOLDING CORP (ICU) has a profitability rating of 1 / 10.


What is the financial health of SEASTAR MEDICAL HOLDING CORP (ICU) stock?

The financial health rating of SEASTAR MEDICAL HOLDING CORP (ICU) is 6 / 10.